You are here

Technology Management

 

Mountain View, California-based AliveCor, which makes the personal electrocardiogram, Kardia Mobile, has plans to enhance the device with a new detection feature through a collaboration with Mayo Clinic.

Because liver transplants are among the surgeries at the highest risk to cause cardiac problems, researchers at Northwestern Medicine in Chicago have developed an app that can predict a liver transplant patient’s one-year risk of dying or being hospitalized due to a heart attack or other cardiac event.

According to a new study, pacemakers and other cardiac devices could help solve forensic cases by revealing a person’s time and cause of death where an autopsy can’t.

St. Louis-based Stereotaxis, a cardiac technology maker, launched its e-Contact module in Europe last week, bringing a device to market that can significantly ease the jobs of cardiologists.

Dublin-based Medtronic revealed encouraging results from a study completed on its Micra Transcatheter Pacing System (TPS), which showed a 99.6 percent implant success rate and low chances of major complications occurring.

 

Recent Headlines

Two Biotronik ICD systems receive FDA approval

Two implantable cardioverter defibrillator (ICD) systems made by Biotronik were approved by the U.S. Food and Drug Administration, the company announced July 19.

AliveCor, Mayo work to develop technology to detect congenital heart condition

Mountain View, California-based AliveCor, which makes the personal electrocardiogram, Kardia Mobile, has plans to enhance the device with a new detection feature through a collaboration with Mayo Clinic.

Northwestern develops app to predict cardiac risk in liver transplant recipients

Because liver transplants are among the surgeries at the highest risk to cause cardiac problems, researchers at Northwestern Medicine in Chicago have developed an app that can predict a liver transplant patient’s one-year risk of dying or being hospitalized due to a heart attack or other cardiac event.

Cardiac devices could help identify cause, time of death in forensic cases

According to a new study, pacemakers and other cardiac devices could help solve forensic cases by revealing a person’s time and cause of death where an autopsy can’t.

Stereotaxis launches cardiac catheter module in Europe

St. Louis-based Stereotaxis, a cardiac technology maker, launched its e-Contact module in Europe last week, bringing a device to market that can significantly ease the jobs of cardiologists.

Northwell Health, Peerbridge team up to expand the use of remote electrocardiogram

Northwell Health, the largest healthcare provider in New York, has partnered with Peerbridge Health to help further develop a new remote electrocardiogram as the company seeks approval from the U.S. Food and Drug Administration (FDA).

FDA issues Class 1 recall of Abbott-Thoratec LVAS controller

The U.S. Food and Drug Administration (FDA) has announced a Class 1 recall of the HeartMate II LVAS Pocket System Controller from Abbott-Thoratec.

HRS2017: Study finds Medtronic’s smallest pacemaker safe, effective

Dublin-based Medtronic revealed encouraging results from a study completed on its Micra Transcatheter Pacing System (TPS), which showed a 99.6 percent implant success rate and low chances of major complications occurring.

Biotronik shows off new MRI AutoDetect technology at HRS2017

Just last week, Lake Oswego, Oregon-based Biotronik announced that two of its new products, the SentusProMRI and its MultiPole Pacing technology, were approved by the U.S. Food and Drug Administration (FDA). This week at the annual Heart Rhythm Society conference in Chicago, the company showed off the new devices.

Abbott smartphone-compatible cardiac monitor gains CE Mark

Abbott announced its smartphone-compatible insertable cardiac monitor (ICM) has gained CE Mark. The device allows physicians to remotely monitor patients, potentially diagnosing arrhythmias and atrial fibrillation (AFib).

Pages